N

Neurexis Therapeutics

3 employees

Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia. Show more Show less

Investor insights

Funding rounds participated in

$3M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$3M

from 1 investors over 1 rounds

N

Neurexis Therapeutics raised $3M on October 16, 2024

Investors: National Institute of Neurological Disorders and Stroke

Neurexis Therapeutics

Investor insights

Funding rounds participated in

Investor type

Basic info

Industry

Sectors

Funding rounds raised

Total raised

FAQ

How to get an intro to Neurexis Therapeutics?

How many funding rounds has Neurexis Therapeutics raised?

What is Neurexis Therapeutics's typical check size?

What type of investor is Neurexis Therapeutics?